Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by princeofcuton Jun 22, 2015 10:26am
146 Views
Post# 23854831

RE:RE:where is the FDA approval????

RE:RE:where is the FDA approval????ROTFLMAO..so dundersticks the best you can compare 208 to is a glass of water..pure idiot is what you are so you must be a rube...your failed attempt at analogy ishilarious, cause dunder we ain't in a desert and i sure hope RVX attracts a smarter class of owner than you...your comment id immediately you know nothing of biotech investing,,,PS meagre shareprice reaction is exactly what i suspect to be...if 208 is not approved in US it is very bad news for 208 and nothing in that NR gives me hope that will occur..the discussion on this MB should be about FDA lack of approval as it relates to typically "odd" comment by DM last week, which led me to believe that FDA approval would not be forthcoming and RVX is abandoning the US (i wouldn't be surprised if the FDA either a) rejected the PIII thingy out of hand or b) required significant changes (ie much larger population) or c) didn't by the RRR thingy)...i wonder if the "adaptive nature" has given way to a more traditional approach...
Bullboard Posts